Sino Siam Biotechnique

Sino-Siam Biotechnique is a prominent biotechnology manufacturer based in Thailand, established as a joint venture between the Thai Government Pharmaceutical Organization (GPO) and Chinese partners. The company specializes in the production of recombinant DNA-derived biopharmaceuticals, including erythropoietin for treating anemia and vaccines for hepatitis B. Operating from a GMP-certified facility in Pathum Thani, Sino-Siam Biotechnique focuses on providing affordable, high-quality biologics to the Southeast Asian market. Its portfolio includes essential medicines that support national healthcare programs, particularly in the fields of nephrology and infectious diseases. The company represents a significant collaboration in technology transfer between Thailand and China in the life sciences sector. It was the first facility in Thailand capable of producing recombinant proteins at a commercial scale.